Health

ExamWorks Announces Strategic Leadership Transition Plan to Further Accelerate Long-Term Growth

ATLANTA, GA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ExamWorks Group (“ExamWorks”), a leading global provider of medical claims management solutions,…

1 month ago

RadNet Names Four Leaders to Expanded Executive Roles

LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient…

1 month ago

LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies

Dr. Bo Rode Hansen, current Board member and Corporate Development Officer named Interim CEO Alex Blyth, Founder and CEO to step…

1 month ago

Day One Completes Acquisition of Mersana Therapeutics

Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma…

1 month ago

Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board

January 06, 2026 09:00 ET  | Source: FemPulse SAN FRANCISCO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- FemPulseTM, a bioelectronic medical…

1 month ago

Visory Health Named to Inc.s Best in Business for Excellence in Social Good

ESTERO, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Visory Health, a patient-first health tech prescription platform that is transforming the…

1 month ago

Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents

ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter the new year, Plum Tree Psychology, a child…

1 month ago

Idorsias daridorexant in women during menopausal transition age with insomnia

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared…

1 month ago

Zealand Pharma to present at the J.P. Morgan Healthcare Conference

January 05, 2026 11:05 ET  | Source: Zealand Pharma Press release – No. 1 / 2026 Zealand Pharma to present…

1 month ago

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

January 04, 2026 16:00 ET  | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals,…

1 month ago